Pravastatin reduces restenosis two years after percutaneous transluminal coronary angioplasty (REGRESS trial).

No abstract is available for this paper.

• Publication year

  2000

• Venue

  American Journal of Cardiology

• Publication date

  2000-10-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1016/S0002-9149(00)01073-0PMID 11018193
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Cholesterol reduction rapidly improves endothelial function after acute coronary syndromes. The RECIFE (reduction of cholesterol in ischemia and function of the endothelium) trial.

  1999cited by this paper
• Does angiography six months after coronary intervention influence management and outcome? Benestent II Investigators.

  1999cited by this paper
• A randomized placebo-controlled trial of fluvastatin for prevention of restenosis after successful coronary balloon angioplasty; final results of the fluvastatin angiographic restenosis (FLARE) trial.

  1999cited by this paper
• Usefulness of the substitution of nonangiographic end points (death, acute myocardial infarction, coronary bypass and/or repeat angioplasty) for follow-up coronary angiography in evaluating the success of coronary angioplasty in patients with angina pectoris.

  1998cited by this paper
• Balloon angioplasty versus new device intervention: clinical outcomes. A comparison of the NHLBI PTCA and NACI registries.

  1998cited by this paper
• Effect of pravastatin on angiographic restenosis after coronary balloon angioplasty. The PREDICT Trial Investigators. Prevention of Restenosis by Elisor after Transluminal Coronary Angioplasty.

  1997cited by this paper
• Remodeling of the coronary artery after vascular injury.

  1997cited by this paper
• Remodeling of human coronary arteries undergoing coronary angioplasty or atherectomy.

  1997cited by this paper
• Late regression of the dilated site after coronary angioplasty: a 5-year quantitative angiographic study.

  1997cited by this paper
• Review of recent clinical trials of lipid lowering in coronary artery disease.

  1997cited by this paper
• Pharmacological approaches for the prevention of restenosis after percutaneous coronary intervention.

  1997cited by this paper
• The molecular bases of restenosis.

  1997cited by this paper
• Arterial Remodeling: A Critical Factor in Restenosis

  1997cited by this paper
• Late Regression of the Dilated Site After Coronary Angioplasty A 5-Year Quantitative Angiographic Study

  1996cited by this paper
• Reduction of transient myocardial ischemia with pravastatin in addition to the conventional treatment in patients with angina pectoris. REGRESS Study Group.

  1996cited by this paper
• Arterial remodeling after coronary angioplasty: a serial intravascular ultrasound study.

  1996cited by this paper
• Our preoccupation with coronary luminology. The dissociation between clinical and angiographic findings in ischemic heart disease.

  1995cited by this paper
• Effects of lipid lowering by pravastatin on progression and regression of coronary artery disease in symptomatic men with normal to moderately elevated serum cholesterol levels. The Regression Growth Evaluation Statin Study (REGRESS).

  1995cited by this paper
• Restenosis after percutaneous transluminal coronary angioplasty: have we been aiming at the wrong target?

  1995cited by this paper
• Percutaneous transluminal coronary angioplasty.

  1994cited by this paper
• Lack of effect of lovastatin on restenosis after coronary angioplasty. Lovastatin Restenosis Trial Study Group.

  1994cited by this paper
• The emerging concept of vascular remodeling.

  1994cited by this paper
• Relation between coronary artery stenosis assessed by visual, caliper, and computer methods and exercise capacity in patients with single-vessel coronary artery disease. The Veterans Affairs ACME Investigators.

  1994cited by this paper
• Accuracy of Electronic Digital Calipers Compared With Quantitative Angiography in Measuring Coronary Arterial Diameter

  1993cited by this paper
• Restenosis after percutaneous transluminal coronary angioplasty.

  1992cited by this paper
• Prevention of restenosis by lovastatin after successful coronary angioplasty.

  1991cited by this paper
• Restenosis after successful percutaneous transluminal coronary angioplasty.

  1990cited by this paper
• Restenosis after successful percutaneous transluminal coronary angioplasty: serial angiographic follow-up of 229 patients.

  1988cited by this paper
• Incidence of restenosis after successful coronary angioplasty: a time-related phenomenon. A quantitative angiographic study in 342 consecutive patients at 1, 2, 3, and 4 months.

  1988cited by this paper
• Three year anatomic, functional and clinical follow-up after successful percutaneous transluminal coronary angioplasty.

  1987cited by this paper
• Percutaneous transluminal coronary angioplasty.

  1984cited by this paper

• Prevención secundaria con estatinas . Certezas, controversias y expectativas

  2026cites this paper
• Lipid-lowering medication reduces more target lesion than non-target lesion revascularizations: a cohort study.

  2026cites this paper
• Effectiveness of lipid-lowering therapy on mortality and major adverse cardiovascular event outcomes in patients undergoing percutaneous coronary intervention: a network meta-analysis of randomised controlled trials

  2023cites this paper
• Study of the Effect of the Perioperative Administration of Statin on the Prognosis of Percutaneous Coronary Intervention Using the National Health Insurance Claims Database in Japan

  2020cites this paper
• Pravastatin for lowering lipids.

  2020cites this paper
• Atherosclerosis: Making a U Turn.

  2020cites this paper
• Different Statin Effects of ST-elevation Versus Non-ST-Elevation Acute Myocardial Infarction After Stent Implantation.

  2020cites this paper
• Monocyte-mediated drug delivery systems for the treatment of cardiovascular diseases

  2017cites this paper
• Effects of Statin Treatment on Early Outcomes and Restenosis after Carotid Stenting

  2014cites this paper
• Statins and regression of organ damage

  2013influential citation
• Statins and percutaneous coronary intervention: a complementary synergy.

  2013cites this paper
• Therapeutic Potential of Oral Antiproliferative Agents in the Prevention of Coronary Restenosis

  2012cites this paper
• Medical angioplasty - Hope and expectations: An optimistic overview

  2011cites this paper
• Total sleep deprivation augments balloon angioplasty‐induced neointimal hyperplasia in rats

  2011influential citation
• Liposomal Simvastatin Attenuates Neointimal Hyperplasia in Rats

  2010cites this paper
• Statins in prevention of repeat revascularization after percutaneous coronary intervention--a meta-analysis of randomized clinical trials.

  2010cites this paper
• Stents and statins: history, clinical outcomes and mechanisms

  2010cites this paper
• Abstract: P746 PREPROCEDURAL C-REACTIVE PROTEIN PREDICTIVE VALUE IN ANGIOGRAPHIC IN-STENT RESTENOSIS AFTER CORONARY STENT PLACEMENT IN PATIENTS WITH STABLE ANGINA

  2009cites this paper
• The pleiotropic effects of statins on endothelial function, vascular inflammation, immunomodulation and thrombogenesis.

  2009cites this paper
• Statine e regressione del danno d’organo

  2009cites this paper
• Beneficial effects of statins after percutaneous coronary intervention

  2009cites this paper
• Preprocedural C-reactive protein predictive value in angiographic in-stent restenosis after coronary stent placement in patients with stable angina

  2009cites this paper
• Temporal gene expression analysis of human coronary artery endothelial cells treated with Simvastatin.

  2008cites this paper
• КОМБИНИРОВАННАЯ ТЕРАПИЯ АРТЕРИАЛЬНОЙ ГИПЕРТЕНЗИИ: В ФОКУСЕ - ФИКСИРОВАННАЯ КОМБИНАЦИЯ АНТАГОНИСТА КАЛЬЦИЯ И ИНГИБИТОРА АПФ

  2008cites this paper
• Effect of early use of low-dose pravastatin on major adverse cardiac events in patients with acute myocardial infarction: the OACIS-LIPID Study.

  2008cites this paper
• Statins exert multiple beneficial effects on patients undergoing percutaneous revascularization procedures.

  2007cites this paper
• Comparison of the Efficacies of Five Different Statins on Inhibition of Human Saphenous Vein Smooth Muscle Cell Proliferation and Invasion

  2007cites this paper
• [Analysis of clinical factors that influence re-stenosis after percutaneous coronary stenting].

  2007cites this paper
• Statin therapy in South-Asian patients: clinical implications beyond lipid lowering?

  2007cites this paper
• Komprehensive Behandlungsstrategien zur Ergebnisoptimierung nach perkutaner koronarer Intervention

  2006cites this paper
• Endothelial dysfunction: a multifaceted disorder (The Wiggers Award Lecture).

  2006cites this paper
• Lipid Control in Patients with Acute Coronary Syndrome Before and After Percutaneous Coronary Intervention and Restenosis

  2006cites this paper
• HEART's Original [臨床研究] 冠インターベンション前後の血清脂質値が急性冠症候群症例の再狭窄におよぼす影響

  2006cites this paper
• Short-term Atorvastatin Treatment Does Not Modify Neointimal Morphology but Reduces MMP-2 Expression in Normocholesterolemic Rabbit Stented Arteries

  2006cites this paper
• Use of fluvastatin following percutaneous coronary intervention

  2005cites this paper
• Elevated preprocedural high-sensitivity C-reactive protein levels are associated with neointimal hyperplasia and restenosis development after successful coronary artery stenting.

  2005cites this paper
• Prognostic significance of simvastatin therapy in patients with ischemic heart failure who underwent percutaneous coronary intervention for acute myocardial infarction.

  2005cites this paper
• Effect of statin on restenosis after radius stent implantation in patients with acute coronary syndrome.

  2005cites this paper
• Coronary stenting and inflammation.

  2005cites this paper
• Percutaneous coronary interventions for coronary artery disease: the long and short of optimizing medical therapy

  2005cites this paper
• Combined treatment with statin and angiotensin-receptor blocker after stenting as a useful strategy for prevention of coronary restenosis.

  2005cites this paper
• HANNA PUHAKKA Gene Therapy for Vascular Thickening

  2005cites this paper
• Preventing restenosis in early drug‐eluting stent era: recent developments and future perspectives

  2004cites this paper
• Preprocedural C-reactive protein is not associated with angiographic restenosis or target lesion revascularization after coronary artery stent placement.

  2004cites this paper
• Effects of statins on vascular structure and function: a systematic review.

  2004cites this paper
• Insights into early and rapid effects of statin therapy after coronary interventions.

  2004cites this paper
• Effects of Low-Dose Atorvastatin on Vascular Responses in Patients Undergoing Percutaneous Coronary Intervention With Stenting

  2004cites this paper
• Inflammation and restenosis after percutaneous coronary interventions.

  2004cites this paper
• Postinterventionelle Behandlung nach peripheren Interventionen

  2004cites this paper
• Atorvastatin reduces remnant lipoproteins and small, dense low-density lipoproteins regardless of the baseline lipid pattern.

  2004cites this paper
• G protein mediated signaling pathways in lysophospholipid induced cell proliferation and survival

  2004influential citation
• THE ROLE OF NEW ANTIHYPERTENSIVE DRUGS IN STROKE PREVENTION

  2004cites this paper
• 3-Hydroxy-3-methylglutaryl coenzyme a (HMG-CoA) reductase inhibitors (statins), atherosclerosis and coronary syndromes.

  2004cites this paper
• Atorvastatin stent coating does not reduce neointimal proliferation after coronary stenting

  2003cites this paper
• The neointimal response to endovascular injury is increased in obese Zucker rats

  2003cites this paper
• Inflammation and restenosis: implications for therapy

  2003cites this paper
• Brief communications of the International Society of Non-Invasive Cardiology, 19th European Congress, May 8-10, 2003 – Istanbul, Turkey

  2003cites this paper
• Need for a moratorium on percutaneous transluminal coronary angioplasty in stable coronary artery disease.

  2002cites this paper
• Prevenção da reestenose pós-angioplastia coronária: mito ou realidade?* Prevention of restenosis after coronary angioplasty: myth or reality?*

  2002cites this paper
• Statins: the new aspirin?

  2002cites this paper
• Early revascularisation and 1-year survival in 14-day survivors of acute myocardial infarction: a prospective cohort study.

  2002cites this paper
• Review Statins: the new aspirin?

  2002cites this paper
• Hypercholesterolemia impairs vascular remodelling after porcine coronary angioplasty.

  2002cites this paper
• Hyperlipidaemia and cardiovascular disease.

  2001cites this paper
• Pravastatin and endothelium dependent vasomotion after coronary angioplasty: the PREFACE trial

  2001cites this paper
• Therapy and clinical trials.

  2001cites this paper
• [Statins do not prevent restenosis after coronary angioplasty: where to go from here?].

  2001cites this paper
• The Lescol ® Intervention Prevention Study (LIPS): a double-blind, placebo-controlled, randomized trial of the long-term effects of fluvastatin after successful transcatheter therapy in patients with coronary heart disease

  2001cites this paper
• Editorial comment Therapy and clinical trials

  2001cites this paper
• Potential Influence of Timing of Low‐Density Lipoprotein Cholesterol Evaluation in Patients with Acute Coronary Syndrome

  2001cites this paper